Add Yahoo as a preferred source to see more of our stories on Google. Dr. Deephak Swaminath and his team at Medical Center Hospital were the first in West Texas to use the Pulse Select PFA (pulsed ...
DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the ...
ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent ...
Dr. Deephak Swaminath and his team at Medical Center Hospital were the first in West Texas to use the Pulse Select PFA (pulsed field ablation) system. Pulse Select PFA is an emerging and newer, ...
Medtronic's PulseSelect PFA System Gets FDA Nod, Revolutionizing Atrial Fibrillation Treatment in US
The FDA approved Medtronic plc's (NYSE:MDT) PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF), an irregular and often very ...
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy Successful launch in Japan follows recent reimbursement approval Approvals across APAC ...
Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results